Special Issue "Advances and Challenges in Stroke Therapy: A Regenerative Prospective"
Deadline for manuscript submissions: 31 July 2023 | Viewed by 1714
2. University Children's Hospital, 11000 Belgrade, Serbia
Interests: electrodiagnostics; rehabilitation; population genetics; physical activity
Special Issues, Collections and Topics in MDPI journals
The multifactorial stroke etiology is creating the need for permanent development of novel and more specific therapies and treatments for pediatric and adult stroke patients. Decades of extensive research in the field of stroke accumulated a significant amount of evidence about inflammation influence in neuronal loss in stroke patients. On the contrary, the association between inflammation and repair processes in ischemic stroke is documented as well. Another important aspect in the recovery of patients after the stroke is genetic determinants that may have a role in complex stroke processes and genetic-dependent immunomodulation in stroke treatment.
In this Special Issue, we would like to highlight the connection between genetic factors, inflammation, and challenges in the development of next-generation therapeutics in stroke and how genetic prediction may advance the application of thrombolytic, antithrombotic, and neuroprotective interventions. Additionally, we would like to focus on therapies for balancing immune reaction and shifting activity from pro-inflammatory to anti-inflammatory, and from neurotoxic to neuroprotective.
The preferred type of manuscripts would be: Reviews, Systematic Reviews, Meta-analyses, Original articles, Evidence-based papers, Guidelines, Recommendations, and Case studies.
Prof. Dr. Dejan Nikolić
Dr. Milena Janković
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- next generation therapeutics
- genetic predisposition